Centre Publications

2026

Please click here for publications from previous years

Author(s) Title Year Citation
Miller J, Diefenbach-Elstob T, Wordsworth R, Deshpande N, Soppe S, Dharmakumara J, Aban M, Peck H, Hussain S, Deng YM, Dapat C, Barr I, Reading P Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2024 2026 Communicable Diseases Intelligence
Pubmed link
doi: 10.33321/cdi.2026.50.014
Kikawa C, Loes AN, Huddleston J, Figgins MD, Steinberg P, Griffiths T, Drapeau EM, Peck H, Barr I, Englund JA, Hensley SE, Bedford T, Bloom JD High-throughput neutralization measurements correlate strongly with evolutionary success of human influenza strains 2026 eLife
Pubmed link
doi: 10.7554/eLife.106811
Neher RA, Huddleston J, Bedford T, Lewis NS, Harvey R, Galiano M, Byrne AMP, James S, Smith D, Łuksza M, Ruchnewitz D, Laessig M, Fujisaki S, Watanabe S, Hasegawa H, Hassell N, Wentworth DE, Kondor R, Deng YM, Dapat C, Subbarao K, Barr I Nomenclature for Tracking of Genetic Variation of Seasonal Influenza Viruses 2026 Influenza and Other Respiratory Viruses
Pubmed link
doi: 10.1111/irv.70230
Kang L, Huang F, Deng YM, Hu G, Wang Y, Li A, Xie H, Wei X, Han Y, Luo M, Barr IG, Gao GF, Wang L, Wang Q Genomic evidence of HMPV resurgence in Beijing: Clade B2 triggers the 2024 winter epidemic peak 2026 Virologica Sinica
Pubmed link
doi: 10.1016/j.virs.2026.01.006.
Chiu SK, Furlong E, Fox A, McKinnon EJ, Sánchez-Ovando S, Mclean-Tooke A, Oommen J, Yeoh DK, Cheung LC, Gottardo NG, Kotecha RS Blinatumomab limits humoral antibody response despite boosting the influenza vaccine schedule in children with B-ALL 2026 Blood Advances
Pubmed link
doi: 10.1182/bloodadvances.2025018688
Xia Y, Farrukee R, Brooks AG, Soler S, Behrendt R, Bartok E, Londrigan SL, Reading PC Host restriction factor SAMHD1 does not restrict seasonal influenza virus replication in human epithelial or macrophage-like cells 2026 Virol J
Pubmed link
doi: 10.1186/s12985-026-03065-w
Earnest L, Ruiz DF, Edeling MA, Montoya JC, Yap AHY, Wong CY, Holz LE, Gras S, Collett S, Cooney JP, Davidson KC, Grimley SL, Purcell DFJ, Roberts J, Mumford J, Tan CW, Wang LF, Godfrey DI, Frieman M, Hans D, Vincan E, Anderson DE, Subbarao K, Pellegrini M, Mackenzie JM, Rockman S, Heath WR, Torresi J Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59 2026 NPJ Vaccines
Pubmed link
doi: 10.1038/s41541-025-01355-y
Dong X, Edwards S, Deng YM, Dapat C, Hirankitti A, Barr IG Sequencing RSV Whole Genome Using a Long Amplicon-Based Method with Oxford Nanopore Technologies 2026 Methods in Molecular Biology
Pubmed link
doi: 10.1007/978-1-0716-5060-8_11

Top of Page